What is the primary function of glucocorticoids like Budesonide in inflammatory bowel disease?

What is the primary function of glucocorticoids like Budesonide in inflammatory bowel disease?

• A. To suppress appetite
• B. To induce remission and reduce inflammation
• C. To stimulate immune response
• D. To promote absorption of nutrients

Answer: (B)

Budesonide is a synthetic glucocorticoid that is commonly used in the management of inflammatory bowel disease (IBD), which includes conditions such as Crohn's disease and ulcerative colitis. The primary function of glucocorticoids like Budesonide in the context of IBD is to induce remission and reduce inflammation. Glucocorticoids exert their effects by binding to glucocorticoid receptors, which leads to alterations in gene expression that ultimately result in the suppression of inflammatory pathways. This action helps to control the immune response in the gut, reducing the excessive inflammation that characterizes IBD. By diminishing the inflammatory response, glucocorticoids alleviate symptoms, promote healing of the intestinal mucosa, and help maintain remission, thus improving the overall quality of life for patients living with these chronic conditions. The other options are not aligned with the primary therapeutic action of glucocorticoids in this context. Suppression of appetite and promotion of nutrient absorption are not core functions associated with their use in treating inflammatory bowel disease. Additionally, glucocorticoids do not stimulate the immune response; rather, they are known for their immunosuppressive effects, which is why they are used to manage conditions characterized

Budesonide is a synthetic glucocorticoid that is commonly used in the management of inflammatory bowel disease (IBD), which includes conditions such as Crohn's disease and ulcerative colitis. The primary function of glucocorticoids like Budesonide in the context of IBD is to induce remission and reduce inflammation.

Glucocorticoids exert their effects by binding to glucocorticoid receptors, which leads to alterations in gene expression that ultimately result in the suppression of inflammatory pathways. This action helps to control the immune response in the gut, reducing the excessive inflammation that characterizes IBD. By diminishing the inflammatory response, glucocorticoids alleviate symptoms, promote healing of the intestinal mucosa, and help maintain remission, thus improving the overall quality of life for patients living with these chronic conditions.

The other options are not aligned with the primary therapeutic action of glucocorticoids in this context. Suppression of appetite and promotion of nutrient absorption are not core functions associated with their use in treating inflammatory bowel disease. Additionally, glucocorticoids do not stimulate the immune response; rather, they are known for their immunosuppressive effects, which is why they are used to manage conditions characterized